Keros Therapeutics (KROS) Stock Highlights

54.14 | +0.97%

2024-11-21 02:34:20

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The companys protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cell counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

Statistics

Range Today

52.63 54.87

Volume Today 408.4K

Range 1 Year

27.31 73

Volume 1 Year 94.64M

Range 3 Year

24.38 73

Volume 3 Year 195.31M

Range 10 Year

19.1 88.8

Volume 10 Year 253.78M

Highlights

Market Capitalization 2.75B (mid)

Floating Shares 34.96M

Current Price 54.14

Price To Earnings -12.76

Price To Revenue 3.44K

Price To Book 5

Earnings Per Share -5.27

Payout Ratio 0%

Performance

Latest +0.97%

1 Month -11%

3 Months +14.24%

6 Months +2.73%

1 Year +78.33%

3 Years -8.75%

5 Years +159.66%

10 Years +159.66%

Benchmarks

Market Capitalization

70 / 368

Gross Profits

232 / 278

Total Revenue

286 / 300

Total Rank

175 / 368

Free Cashflow

263 / 352

Performance 5 years

48 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.